PTPN2 and hepatocellular carcinoma: LncRNATINCR has been reported to directly bind TCPTP and inhibit STAT3 dephosphorylation, thereby promoting STAT3 activation and the role of its downstream target genes in HCC progression and tumorigenicity [33].